CLINICAL_TRIALS
trial_result
· 2017-02-15
Clinical Trial Update: Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT) [Phase 2]
Summary
A Phase 2 trial studied liraglutide, a GLP-1 receptor agonist, in patients with acute heart failure. The study has completed and its results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Duke University | Conditions: Acute Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2017-02-15